Association of National Identity and Trust in Government with COVID-19 Vaccination and Brand Choice in Taiwan

Overview

Journal J Community Health

Publisher Springer

Specialty Public Health

Date 2024 Mar 24

PMID 38522040

Authors

Chun-Tung Kuo

Ruoh-Rong Yu

Affiliations

Soon will be listed here.

Abstract

In Taiwan, hesitancy regarding COVID-19 vaccination centered more on the choice of vaccine brand than on the decision to vaccinate. However, there is limited research exploring the factors influencing COVID-19 vaccine brand preferences from a sociopolitical perspective. Thus, we aimed to examine how Taiwanese national identity and trust in government influence vaccination status and vaccine brand choice, using longitudinal data from 2020, 2021, and 2023. This study utilized data from the Taiwan Panel Study of Family Dynamics 2020 survey, and combined it with data from two self-administered surveys conducted in 2021 and 2023. We focused on four vaccines commonly administered in Taiwan: AstraZeneca, Moderna, Pfizer-BioNTech, and the domestically-developed Medigen. Using Poisson regression models with robust standard errors, we assessed the effects of national identity and trust in government on the choice of COVID-19 vaccine brand. By analyzing data from 2361 participants, we found that national identity and trust in government were associated with the likelihood of COVID-19 vaccination, the number of vaccine doses received, and the brand of vaccine taken. Those who identified themselves as Taiwanese were more inclined to receive the Medigen and AstraZeneca vaccines, but less willing to receive Pfizer-BioNTech vaccine. Those who trusted the government were more likely to prefer and receive the Medigen vaccine. Conversely, those who didn't trust the government were less likely to prefer Medigen and AstraZeneca vaccines, but were willing to receive Pfizer-BioNTech vaccine. Vaccine brand preferences and uptake in Taiwan were affected by individuals' national identity and their trust in government. This highlights the critical role of sociopolitical factors in shaping public health strategies.

References

Steinbrook R . Lessons From the Success of COVID-19 Control in Taiwan. JAMA Intern Med. 2021; 181(7):922. DOI: 10.1001/jamainternmed.2021.1625. View

Summers J, Cheng H, Lin H, Telfar Barnard L, Kvalsvig A, Wilson N . Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health West Pac. 2021; 4:100044. PMC: 7577184. DOI: 10.1016/j.lanwpc.2020.100044. View

Wang C, Ng C, Brook R . Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing. JAMA. 2020; 323(14):1341-1342. DOI: 10.1001/jama.2020.3151. View

Yen M, Yen Y, Chen S, Lee T, Huang K, Chan T . Learning from the past: Taiwan's responses to COVID-19 versus SARS. Int J Infect Dis. 2021; 110:469-478. PMC: 8178059. DOI: 10.1016/j.ijid.2021.06.002. View

Dyer O . Covid-19: Variants are spreading in countries with low vaccination rates. BMJ. 2021; 373:n1359. DOI: 10.1136/bmj.n1359. View

Wu C, Chou Y, Lin F, Hsieh C, Wu D, Peng C . Epidemiological features of domestic and imported cases with COVID-19 between January 2020 and March 2021 in Taiwan. Medicine (Baltimore). 2021; 100(39):e27360. PMC: 8483820. DOI: 10.1097/MD.0000000000027360. View

Sheng W, Lin P, Cheng Y, Wu Y, Hsieh M, Yang H . Immunogenicity and safety of heterologous booster with protein-based COVID-19 vaccine (NVX-CoV2373) in healthy adults: A comparative analysis with mRNA vaccines. J Formos Med Assoc. 2023; 123(3):340-346. DOI: 10.1016/j.jfma.2023.10.012. View

Lee Y, Wu W . Key Drivers of COVID-19 Vaccine Hesitancy: A Perspective of Collectivism. Healthcare (Basel). 2023; 11(2). PMC: 9859124. DOI: 10.3390/healthcare11020176. View

Li S, Chen H, Liu P, Shi Z, Lin Y, Tsai C . Case report of acute encephalitis following the AstraZeneca COVID-19 vaccine. Int J Rheum Dis. 2022; 25(8):950-956. PMC: 9349981. DOI: 10.1111/1756-185X.14372. View

10.

Yuan Y, Yeo S, Lee K . Different roles of interpersonal trust and institutional trust in motivating older adults to receive COVID-19 vaccines in Singapore. Soc Sci Med. 2023; 340:116475. DOI: 10.1016/j.socscimed.2023.116475. View

11.

Silver A . Why Taiwan approved its own vaccine before phase III trials. BMJ. 2021; 374:n2104. DOI: 10.1136/bmj.n2104. View

12.

Schaffer DeRoo S, Pudalov N, Fu L . Planning for a COVID-19 Vaccination Program. JAMA. 2020; 323(24):2458-2459. DOI: 10.1001/jama.2020.8711. View

13.

Chiang C, Kuo J, Liu J . Cueing quality: Unpacking country-of-origin effects on intentions to vaccinate against COVID-19 in Taiwan. Soc Sci Med. 2022; 314:115403. PMC: 9534538. DOI: 10.1016/j.socscimed.2022.115403. View

14.

Gotanda H, Miyawaki A, Tabuchi T, Tsugawa Y . Association Between Trust in Government and Practice of Preventive Measures During the COVID-19 Pandemic in Japan. J Gen Intern Med. 2021; 36(11):3471-3477. PMC: 8218973. DOI: 10.1007/s11606-021-06959-3. View

15.

Pak A, McBryde E, Adegboye O . Does High Public Trust Amplify Compliance with Stringent COVID-19 Government Health Guidelines? A Multi-country Analysis Using Data from 102,627 Individuals. Risk Manag Healthc Policy. 2021; 14:293-302. PMC: 7851580. DOI: 10.2147/RMHP.S278774. View

16.

Shanka M, Menebo M . When and How Trust in Government Leads to Compliance with COVID-19 Precautionary Measures. J Bus Res. 2021; 139:1275-1283. PMC: 8559780. DOI: 10.1016/j.jbusres.2021.10.036. View

17.

Van Bavel J, Cichocka A, Capraro V, Sjastad H, Nezlek J, Pavlovic T . National identity predicts public health support during a global pandemic. Nat Commun. 2022; 13(1):517. PMC: 8792004. DOI: 10.1038/s41467-021-27668-9. View

18.

Barcelo J, Sheen G, Tung H, Wu W . Vaccine nationalism among the public: A cross-country experimental evidence of own-country bias towards COVID-19 vaccination. Soc Sci Med. 2022; 310:115278. PMC: 9376148. DOI: 10.1016/j.socscimed.2022.115278. View

19.

Trent M, Seale H, Chughtai A, Salmon D, MacIntyre C . Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia. Vaccine. 2021; 40(17):2498-2505. PMC: 8220944. DOI: 10.1016/j.vaccine.2021.06.048. View

20.

Oost P, Yzerbyt V, Schmitz M, Vansteenkiste M, Luminet O, Morbee S . The relation between conspiracism, government trust, and COVID-19 vaccination intentions: The key role of motivation. Soc Sci Med. 2022; 301:114926. PMC: 8928706. DOI: 10.1016/j.socscimed.2022.114926. View